Extendicare (EXE) was up 10% on its Q4 results, which showed continued strength in the home health care segment - with 15% organic volume growth…

… and contribution from its recent $570M acquisition of CTG. Combined with consistent mid-single-digit growth in long-term care, the company’s scale is driving margin expansion…

… which has kept valuation in check, despite a >300% run in shares over the past three years. With an aging population and supply constraints in long-term care…

… Extendicare is well positioned to keep the momentum going.

You might be interested in…

Disclaimer: Content on this site, including research reports, is provided by Bullpen Finance Inc. for informational purposes only and does not constitute investment advice. Bullpen Finance Inc. receives compensation from issuers for research coverage; such compensation does not influence opinions expressed. For complete disclosures, please see our Legal & Disclosures section.